Plex Pharmaceuticals Inc - Company Review
Plex Pharmaceuticals Inc - Company ReviewSummary
Plex Pharmaceuticals Inc (Plex), formerly CalAsia Pharmaceuticals Inc, is a biotechnology company that discovers drug like small molecules. The company offers drug discovery programs for neurodegenerative disorders, non-surgical cataracts, central nervous system (CNS) refractory tumors and infectious diseases. It develops treatments for proteopathic neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic amyotrophic lateral sclerosis. Plex discovers drug like small molecules to develop treatments for CNS or systemic oncology, degenerative CNS disorders, and infectious diseases. The company technologies include fragment-based drug discovery, NMR and SPR fragment screening and hit to lead discovery technology platforms. Plex is headquartered in San Diego, California, the US.
This comprehensive company report of Plex Pharmaceuticals Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.